Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

108
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
108
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

124
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
124
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

3.4K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
3.4K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

332
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
332
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

126
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
126
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

223
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
223

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Big Data-Driven Video Anomaly Detection Using VideoMAE for Visual Analytics in CCTV Surveillance.

Big data·2026
Same author

Development of AI based behavioral feature patterns on influencing asymptomatic cardiovascular disease attributes: a dataset standardization approach.

Scientific reports·2026
Same author

Realistic benchmark RBD360 dataset for quality assessment of random user generated 360° videos.

Scientific reports·2026
Same author

Quantitative investigation on working memory patterns through EEG based on visual attention task for children with learning disability.

Frontiers in systems neuroscience·2026
Same author

BC-SwinNet: Swin transformer and CNN with multi-objective optimization for multi-class breast cancer detection using Histopathological images.

Scientific reports·2026
Same author

IoT-aware extreme machine learning for efficient health monitoring.

BMC health services research·2026
Same journal

EXPRESSION OF CONCERN: An Upstream Open Reading Frame Regulates Vasculogenic Mimicry of Glioma via ZNRD1-AS1/miR-499a-5p/ELF1/EMI1 Pathway.

Journal of cellular and molecular medicine·2026
Same journal

The Role of Long Noncoding RNAs in Modulation of Stress Granules in Cancer.

Journal of cellular and molecular medicine·2026
Same journal

Serum Leptin Exacerbates Osteoarthritis by Promoting Subchondral Bone H-Type Vessel Angiogenesis via Activation of the PI3K/AKT Pathway.

Journal of cellular and molecular medicine·2026
Same journal

Molecular Subtype Identification and Prognostic Prediction of Pancreatic Cancer Based on m6A/m5C/m1A-Related Genes.

Journal of cellular and molecular medicine·2026
Same journal

Assessment of hESC-IMRC-Exo for Cardiac and Cerebral Injuries Post-Cardiac Arrest Resuscitation: Safety, Pharmacokinetics, and Efficacy.

Journal of cellular and molecular medicine·2026
Same journal

Dynamic Transcriptomic Profiling of Mouse Endometrium Across the Estrous Cycle Reveals Phase-Specific Regulatory Networks Underlying Cyclic Remodelling.

Journal of cellular and molecular medicine·2026
See all related articles

Related Experiment Video

Updated: Sep 9, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.5K

A Unified Hybrid Model for Cardiovascular Risk Prediction: Merging Statistical, Kernel-Based and Neural Approaches.

Mudassir Khan1, Rupali A Mahajan2, Nithya Rekha Sivakumar3

  • 1Department of Computer Science, College of Computer Science, Applied College Tanumah, King Khalid University, Abha, Saudi Arabia.

Journal of Cellular and Molecular Medicine
|August 28, 2025
PubMed
Summary
This summary is machine-generated.

A new hybrid machine learning approach (HMLCRP) improves cardiovascular disease risk prediction by combining logistic regression, support vector machines, and neural networks for more accurate and reliable results.

Keywords:
cardiovascular risk predictionhybrid machine learninglogistic regressionneural networkspredictive analyticssupport vector machines

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.7K

Related Experiment Videos

Last Updated: Sep 9, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.5K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.7K

Area of Science:

  • Cardiology
  • Machine Learning
  • Predictive Analytics

Background:

  • Cardiovascular diseases (CVDs) remain the leading global cause of mortality.
  • Traditional machine learning models struggle to accurately capture complex relationships between CVD risk factors and disease onset.
  • Accurate prediction of cardiovascular risk is crucial for effective prevention and management strategies.

Purpose of the Study:

  • To introduce and evaluate a novel hybrid machine learning approach for cardiovascular risk prediction (HMLCRP).
  • To enhance the accuracy and reliability of CVD risk assessment by integrating diverse machine learning algorithms.
  • To identify key cardiovascular risk factors for improved predictive modeling.

Main Methods:

  • Developed a hybrid machine learning approach (HMLCRP) combining logistic regression (LR), support vector machines (SVMs), and neural networks (NNs).
  • Incorporated critical risk factors: blood pressure, family history, stress, age, sex, cholesterol, BMI, and lifestyle choices.
  • Trained and validated the HMLCRP model using benchmark datasets: Cardio statistics, Heart Disease, and Framingham Heart Study datasets.

Main Results:

  • The HMLCRP demonstrated superior predictive performance compared to individual machine learning models.
  • Evaluation metrics including accuracy, precision, recall, and F1-score confirmed the model's effectiveness.
  • The hybrid approach successfully leveraged the strengths of LR, SVM, and NNs for robust classification and risk prediction.

Conclusions:

  • The HMLCRP represents a significant advancement in personalized healthcare for cardiovascular risk management.
  • This model enables proactive risk assessment and facilitates early intervention strategies to prevent CVD.
  • The integration of multiple machine learning techniques offers a more accurate and reliable tool for clinical decision-making.